14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
AUSF vs EMBD: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Global X Adaptive U.S. Factor ETF (AUSF) is the stronger overall head-to-head candidate over Global X Emerging Markets Bond ETF (EMBD) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). AUSF carries a Unified Composite Score of 51.0/100 (HOLD) at $51.28 (N/M Forward P/E, N/A operating margin), whereas EMBD carries 28.7/100 (SELL) at $22.59 (N/M Forward P/E, N/A operating margin).
Technical & Structure Timing Caution: AUSF is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.7); meanwhile EMBD is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 42.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AUSF vs EMBD. Trailing 12-month operating profitability (AUSF N/A vs EMBD N/A) and valuation multiples (AUSF N/M vs EMBD N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ AUSF vs EMBD Key Questions & Quantitative Answers
As of Nov 16, 2026, Global X Adaptive U.S. Factor ETF (AUSF) is the stronger overall head-to-head candidate over Global X Emerging Markets Bond ETF (EMBD) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). AUSF carries a Unified Composite Score of 51.0/100 (HOLD) at $51.28 (N/M Forward P/E, N/A operating margin), whereas EMBD carries 28.7/100 (SELL) at $22.59 (N/M Forward P/E, N/A operating margin). Technical & Structure Timing Caution: AUSF is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.7); meanwhile EMBD is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 42.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
AUSF and EMBD split Growth & Scale metrics: AUSF posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with EMBD at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, AUSF generates N/A in USD-normalized revenue versus N/A for EMBD. In operating R&D and SG&A reinvestment, AUSF deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for EMBD.
AUSF and EMBD trade at balanced relative valuation multiples. AUSF trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas EMBD trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AUSF (N/A ROE) versus EMBD (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, AUSF carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.37β · 28% Vol realized risk). By comparison, EMBD carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.25β · 8% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.